Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1320 Articles

Chris Lange | Jan 22, 2019 at 8:30 AM EST

Johnson & Johnson Earnings: When Good Enough Just Isn’t Good Enough

Johnson & Johnson released better-than-expected fourth-quarter financial results before the markets opened on Tuesday.

Trey Thoelcke | Jan 20, 2019 at 9:35 AM EST

7 of This Week’s Most-Anticipated Earnings Reports

Now that the fourth-quarter earnings reporting season has kicked off, more major companies will be sharing their results this week,…

Jon C. Ogg | Dec 18, 2018 at 9:20 AM EST

Boeing and J&J Both Offer New Incentives for Investors After Big Losses

These two members of the thirty Dow Jones industrial average index have been under siege and are now fighting back.

Chris Lange | Dec 14, 2018 at 11:35 AM EST

Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder

Johnson & Johnson shares dropped on Friday after it came public that the company knew for decades that its baby…

Jon C. Ogg | Nov 27, 2018 at 6:45 AM EST

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019…

Jon C. Ogg | Nov 7, 2018 at 11:00 AM EST

After the Midterm Elections, 10 Defensive Stocks to Buy for 2019

These 10 companies that are likely to have safer business models and will offer some defensive positioning if the economic…

Chris Lange | Oct 16, 2018 at 8:35 AM EDT

Should Johnson & Johnson Be Getting More Out of Q3 Earnings?

Johnson & Johnson reported better-than-expected third-quarter financial results before the markets opened on Thursday.

Chris Lange | Oct 15, 2018 at 10:15 AM EDT

What to Expect When Johnson & Johnson Reports Tuesday

Johnson & Johnson is scheduled to report its third-quarter financial results early Tuesday, and analysts expect solid growth on the…

Chris Lange | Oct 14, 2018 at 7:10 AM EDT

Goldman Sachs, IBM, Amex and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of Johnson & Johnson, Procter & Gamble and the other Dow Jones…

Chris Lange | Oct 4, 2018 at 11:40 AM EDT

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of…

Paul Ausick | Sep 25, 2018 at 4:01 PM EDT

Intel, UnitedHealth Sink the Dow Tuesday

Intel, UnitedHealth, Johnson & Johnson, and 3M Company led the Dow's Tuesday drop.

Paul Ausick | Sep 5, 2018 at 4:01 PM EDT

Visa, Microsoft Hold Back the Dow Wednesday

Trading in the Dow 30 stocks was essentially flat Wednesday with Visa and Microsoft the leading losers while Caterpillar and…

Paul Ausick | Aug 20, 2018 at 4:01 PM EDT

Nike, Johnson & Johnson Lift the Dow Monday

Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.

Jon C. Ogg | Aug 14, 2018 at 5:35 PM EDT

Major Changes Seen in Berkshire Hathaway and Warren Buffett Stock Holdings

The more recent observations about Buffett's portfolio changes coming into mid-2018 have been quite different than many of the historic and traditional…

Jon C. Ogg | Aug 6, 2018 at 10:30 AM EDT

The Next 10 US Companies That Might Catch Apple in the $1 Trillion Value Club

It may not happen overnight, and a solid market correction would almost certainly interfere, but there are many companies that…

1 … 37 38 39 40 41 … 89

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Johnson & Johnson Earnings: When Good Enough Just Isn’t Good Enough

7 of This Week’s Most-Anticipated Earnings Reports

Boeing and J&J Both Offer New Incentives for Investors After Big Losses

Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

After the Midterm Elections, 10 Defensive Stocks to Buy for 2019

Should Johnson & Johnson Be Getting More Out of Q3 Earnings?

What to Expect When Johnson & Johnson Reports Tuesday

Goldman Sachs, IBM, Amex and More Dow Stocks Reporting This Week

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Intel, UnitedHealth Sink the Dow Tuesday

Visa, Microsoft Hold Back the Dow Wednesday

Nike, Johnson & Johnson Lift the Dow Monday

Major Changes Seen in Berkshire Hathaway and Warren Buffett Stock Holdings

The Next 10 US Companies That Might Catch Apple in the $1 Trillion Value Club

Wall Street Loves SanDisk, but Retail Is Strangely Silent

Playing up the irony (small gig, real cost): “He Took a $20,000 Consulting Gig at 70. It Cost Him $1,148 in Medicare Premiums He Never Saw Coming.

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Altria, Circle Internet, Coreweave, Digital Ocean, IBM, Keel Infrastructure, Nebius Group, Trimble, Vornado Realty, and More

Playing up the irony (small gig, real cost): "He Took a $20,000 Consulting Gig at 70. It Cost Him $1,148 in Medicare Premiums He Never Saw Coming.

A Tiny Home Looks Like Freedom on a Social Security Check. The Hidden Bills Say Otherwise.

Wall Street Loves SanDisk, but Retail Is Strangely Silent

Playing up the irony (small gig, real cost): “He Took a $20,000 Consulting Gig at 70. It Cost Him $1,148 in Medicare Premiums He Never Saw Coming.

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Johnson & Johnson Earnings: When Good Enough Just Isn’t Good Enough

7 of This Week’s Most-Anticipated Earnings Reports

Boeing and J&J Both Offer New Incentives for Investors After Big Losses

Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

After the Midterm Elections, 10 Defensive Stocks to Buy for 2019

Should Johnson & Johnson Be Getting More Out of Q3 Earnings?

What to Expect When Johnson & Johnson Reports Tuesday

Goldman Sachs, IBM, Amex and More Dow Stocks Reporting This Week

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Intel, UnitedHealth Sink the Dow Tuesday

Visa, Microsoft Hold Back the Dow Wednesday

Nike, Johnson & Johnson Lift the Dow Monday

Major Changes Seen in Berkshire Hathaway and Warren Buffett Stock Holdings

The Next 10 US Companies That Might Catch Apple in the $1 Trillion Value Club

Wall Street Loves SanDisk, but Retail Is Strangely Silent

Playing up the irony (small gig, real cost): “He Took a $20,000 Consulting Gig at 70. It Cost Him $1,148 in Medicare Premiums He Never Saw Coming.

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Altria, Circle Internet, Coreweave, Digital Ocean, IBM, Keel Infrastructure, Nebius Group, Trimble, Vornado Realty, and More

Featured Reads

Playing up the irony (small gig, real cost): "He Took a $20,000 Consulting Gig at 70. It Cost Him $1,148 in Medicare Premiums He Never Saw Coming.

A Tiny Home Looks Like Freedom on a Social Security Check. The Hidden Bills Say Otherwise.